glp-1 agonists thyroid cancer glp 1 and family history of GLP-1R were studied in thyroid cancers. Both Liraglutide and Glucagon-like peptide 1 receptor agonists
Description
Here we highlight data informing the safety, efficacy, and potential utility of new and emerging glucagon-like peptide-1 medicines
Interestingly, agmatine, a metabolite produced by the gut bacterium Bacteroides vulgatus was shown to impair ovarian function by inhibiting GLP-1 secretion through activation of the farnesoid X receptor (FXR) (Yun et al., 2024)
Cagrilintide, an amylin analogue, is advancing in combination with semaglutide in the Phase III CagriSema programme
149: 574579 [DOI] [PubMed] [Google Scholar] 135.Lamari Y, Boissard C, Moukhtar MS, et al
Nature Pan R, Wang L, Xu X, et al
